Loading...
News2019-02-08T15:19:04-05:00

NEWS FROM REVEN

09/21/2018|

Reven announced today that Peter Pacult has been promoted to the position of Senior Director [...]

09/18/2018|

SAD Cohort 3 doses subjects; Cohort 3 has finished.

09/13/2018|

SAD Cohort 2 doses subjects; Cohort 2 has finished.

09/09/2018|

SAD Cohort 1B doses subjects; Cohort 1 has finished.

09/07/2018|

Reven's Phase 1 Clinical Trial Begins. Reven doses their first subjects (Cohort 1A) under open [...]